Total Payments
$86,738
2024 Payments
$48,955
Companies
31
Transactions
424
Medicare Patients
4,486
Medicare Billing
$865,819
Payment Breakdown by Category
Other$75,617 (87.2%)
Food & Beverage$7,154 (8.2%)
Travel$3,399 (3.9%)
Education$324.91 (0.4%)
Consulting$243.34 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,617 | 53 | 87.2% |
| Food and Beverage | $7,154 | 332 | 8.2% |
| Travel and Lodging | $3,399 | 16 | 3.9% |
| Education | $324.91 | 21 | 0.4% |
| Consulting Fee | $243.34 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $32,640 | 45 | $0 (2024) |
| Lilly USA, LLC | $20,949 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16,727 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $11,537 | 74 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $685.88 | 41 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $490.87 | 13 | $0 (2024) |
| Travere Therapeutics, Inc. | $460.96 | 21 | $0 (2024) |
| Amgen Inc. | $395.39 | 20 | $0 (2024) |
| Vifor Pharma, Inc. | $332.37 | 20 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $269.81 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,955 | 138 | Lilly USA, LLC ($20,949) |
| 2023 | $3,926 | 76 | Bayer Healthcare Pharmaceuticals Inc. ($2,300) |
| 2022 | $31,102 | 72 | Bayer HealthCare Pharmaceuticals Inc. ($30,267) |
| 2021 | $874.25 | 49 | AstraZeneca Pharmaceuticals LP ($214.14) |
| 2020 | $547.76 | 31 | AstraZeneca Pharmaceuticals LP ($145.37) |
| 2019 | $691.56 | 29 | AstraZeneca Pharmaceuticals LP ($217.34) |
| 2018 | $576.80 | 24 | Keryx Biopharmaceuticals, Inc. ($171.59) |
| 2017 | $64.47 | 5 | Mallinckrodt LLC ($25.23) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Nephrology | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,025.00 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,675.00 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $21.98 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $545.00 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $97.09 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.99 | General |
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.18 | General |
| Category: NEPHROLOGY | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $83.08 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.74 | General |
| 11/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.83 | General |
| 10/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: LUPUS NEPHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 925 | 1,875 | $487,050 | $170,383 |
| 2022 | 12 | 1,008 | 2,060 | $540,820 | $185,694 |
| 2021 | 12 | 1,211 | 2,667 | $717,340 | $265,970 |
| 2020 | 15 | 1,342 | 2,989 | $708,150 | $243,773 |
Total Patients
4,486
Total Services
9,591
Medicare Billing
$865,819
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 290 | 792 | $126,960 | $51,394 | 40.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 111 | $105,450 | $32,079 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 461 | $96,810 | $31,131 | 32.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 103 | 177 | $38,940 | $17,381 | 44.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 102 | 103 | $45,320 | $14,556 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $23,040 | $8,004 | 34.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 48 | $15,360 | $5,055 | 32.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 19 | $18,050 | $4,328 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 48 | $6,720 | $3,029 | 45.1% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 11 | 32 | $6,400 | $2,245 | 35.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 14 | 20 | $4,000 | $1,181 | 29.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 320 | 903 | $144,480 | $52,788 | 36.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 21 | 114 | $108,300 | $32,571 | 30.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 143 | 305 | $67,100 | $25,846 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 335 | $70,350 | $24,189 | 34.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 130 | 132 | $58,080 | $21,059 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $24,840 | $8,700 | 35.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 67 | $21,440 | $7,520 | 35.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 29 | $27,550 | $6,577 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 31 | $4,340 | $2,117 | 48.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 26 | 36 | $7,200 | $2,007 | 27.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 12 | 28 | $5,600 | $1,998 | 35.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 11 | $1,540 | $322.75 | 21.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 383 | 1,137 | $181,920 | $68,320 | 37.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 24 | 170 | $161,500 | $50,364 | 31.2% |
About Dr. Christopher Webster, D.O
Dr. Christopher Webster, D.O is a Internal Medicine healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1437442613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Webster, D.O has received a total of $86,738 in payments from pharmaceutical and medical device companies, with $48,955 received in 2024. These payments were reported across 424 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,617).
As a Medicare-enrolled provider, Webster has provided services to 4,486 Medicare beneficiaries, totaling 9,591 services with total Medicare billing of $865,819. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Rochester Hills, MI
- Active Since 05/23/2011
- Last Updated 10/27/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437442613
Products in Payments
- JARDIANCE (Drug) $37,676
- Kerendia (Drug) $32,640
- LOKELMA (Drug) $10,768
- FARXIGA (Drug) $746.94
- Veltassa (Drug) $575.92
- RAYALDEE (Drug) $498.53
- LUPKYNIS (Drug) $269.81
- TAVNEOS (Drug) $218.45
- JYNARQUE (Drug) $214.79
- ACTHAR (Biological) $211.94
- TARPEYO (Drug) $208.86
- KRYSTEXXA (Biological) $190.64
- BENLYSTA (Biological) $189.08
- Rayaldee (Drug) $172.14
- Auryxia (Drug) $171.59
- FERAHEME (Drug) $120.42
- Velphoro (Drug) $110.60
- ULTOMIRIS (Biological) $98.74
- SOLIRIS (Drug) $94.18
- IBSRELA (Drug) $81.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester Hills
Aya Rifai, Md, MD
Internal Medicine — Payments: $76,838
Internal Medicine $76,838
Gamal Zaki, M.d, M.D
Internal Medicine — Payments: $19,252
Internal Medicine $19,252
Seina Farshadsefat, D.o, D.O
Internal Medicine — Payments: $12,544
Internal Medicine $12,544
Dr. Raad Kasmikha, Md, MD
Internal Medicine — Payments: $12,497
Internal Medicine $12,497
Dr. Reem Jarbou, D.o, D.O
Internal Medicine — Payments: $11,542
Internal Medicine $11,542
Ammar Ghanem, Md, MD
Internal Medicine — Payments: $10,373
Internal Medicine $10,373